Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Desiree Matthews

Nurse Practitioner, Psychiatric/Mental Health Charlotte, NC Nurse Practitioner

NPI 1356700561 CMS profile 10614646

5960 Fairview Rd Ste 400, Charlotte, NC 28210

Open in the dashboard

General payments

$806,878

1,082 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Desiree Matthews of Charlotte, NC is reported in the CMS Open Payments database as having received $806,878 across 1,082 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $268,698 328
2024 General $250,721 352
2023 General $105,492 145
2022 General $93,388 117
2021 General $88,579 140

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Desiree Matthews
  • Nurse Practitioner, Psychiatric/Mental Health median
  • Middle half of Nurse Practitioner, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Desiree Matthews were reported at $268,698. Among 26,152 Nurse Practitioner, Psychiatric/Mental Health profiles paid that year, the median was $258 and the middle half received between $93 and $764.

Show as a table
Year Desiree Matthews Nurse Practitioner, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $88,579 $166 $54–$482 $132
2022 $93,388 $195 $66–$559 $149
2023 $105,492 $233 $82–$673 $160
2024 $250,721 $236 $84–$688 $164
2025 $268,698 $258 $93–$764 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Neurocrine Biosciences, Inc. $330,713 409 payments
  2. E.R. Squibb & Sons, L.L.C. $103,034 97 payments
  3. Teva Pharmaceuticals USA, Inc. $100,495 137 payments
  4. Janssen Pharmaceuticals, Inc $70,765 77 payments
  5. AbbVie, Inc. $56,481 121 payments
  6. Axsome Therapeutics, Inc. $39,292 62 payments
  7. Alkermes, Inc. $18,793 34 payments
  8. Indivior Inc. $16,337 30 payments
  9. Luye Pharma (USA) Ltd. $11,523 9 payments
  10. ITI, Inc. $10,376 24 payments
  11. Other $49,070 82 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $431,922 234 payments
  2. Consulting Fee $231,005 98 payments
  3. Travel and Lodging $100,563 333 payments
  4. Honoraria $22,950 14 payments
  5. Food and Beverage $20,208 395 payments
  6. Education $231 8 payments
Products named General payments · program years 2021–2025
  1. INGREZZA Neuropsychiatry $262,123 329 payments
  2. UZEDY $79,412 101 payments
  3. INVEGA TRINZA $70,958 70 payments
  4. INVEGA SUSTENNA $70,864 78 payments
  5. INGREZZA Neurology $65,263 78 payments
  6. VRAYLAR $48,287 99 payments
  7. Auvelity $39,292 62 payments
  8. COBENFY Neuroscience $23,590 35 payments
  9. Austedo XR $23,011 45 payments
  10. COBENFY Psychiatry/Psychology $17,941 16 payments
  11. Other $136,238 274 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

1,082 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Psychiatric/Mental Health in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record